Colored silicone for implant safety

1. An implantable device, comprising:

a hollow biocompatible shell, configured to be implanted in an organ of a patient; and

filling material, which is configured to fill the shell so as to assume a specified shape of the implantable device, and which is visually distinguished from tissue of the organ that surrounds the implantable device;

wherein the filling material differs in color from the tissue by at least a predefined hue difference, the predefined hue difference is 4 degrees in accordance with a red-green-blue (RGB) hue scale.

2. The implantable device according to claim 1 , wherein the tissue has a first color having a first dominant wavelength, and wherein the filling material has a second color having a second dominant wavelength, which differs from the first wavelength by at least a predefined wavelength difference.

3. The implantable device according to claim 2 , wherein the predefined wavelength difference is 50 nm.

4. The implantable device according to claim 1 , wherein the filling material comprises a fluorescent tracer that is adapted to glow when illuminated with light having a color selected from a list consisting of blue and ultra-violet (UV).

5. The implantable device according to claim 1 , wherein the filling material comprises silicone gel.

6. The implantable device according to claim 1 , wherein the filling material comprises carbon black, which is configured to set a color of the filling material to black.

7. The implantable device according to claim 1 , wherein the filling material comprises barium sulfate, which is configured to set a color of the filling material to white.

8. A method for producing an implantable device, comprising:

providing a hollow biocompatible shell, configured to be implanted in an organ of a patient; and

filling the shell with a filling material, which is configured to assume a specified shape of the implantable device, and which is visually distinguished from tissue of the organ that surrounds the implantable device;

wherein the filling material differs in color from the tissue by at least a predefined hue difference, the predefined hue difference is 4 degrees in accordance with a red-green-blue (RGB) hue scale.

9. The method according to claim 8 , wherein the tissue has a first color having a first dominant wavelength, and wherein the filling material has a second color having a second dominant wavelength, which differs from the first wavelength by at least a predefined wavelength difference.

10. The method according to claim 9 , wherein the predefined wavelength difference is 50 nm.

11. The method according to claim 8 , wherein the filling material comprises silicone gel.

12. The method according to claim 8 , wherein the filling material comprises a fluorescent tracer that is adapted to glow when illuminated with light having a color selected from a list consisting of blue and ultra-violet (UV).

13. The method according to claim 8 , wherein the filling material is configured to shape a size and a contour of the organ.

14. A method for removing residues of a ruptured implantable device, the method comprising:

identifying in an organ of a patient a rupture of an implantable device, the device comprising:

a hollow biocompatible shell; and

filling material, which is configured to fill the shell so as to assume a specified shape of the implantable device, and which is visually distinguished from tissue of the organ that surround the implantable device;

imaging the organ so as to detect residues of the filling material that are visually distinguished from tissue; and

removing the residues from the organ;

wherein the filling material comprises a fluorescent tracer that is adapted to glow when illuminated with light having a color selected from a list consisting of blue and ultra-violet (UV), and wherein imaging the organ comprises illuminating the organ with the light.

15. The method according to claim 14 , wherein imaging the organ comprises applying a minimal invasive imaging procedure.